Viking Therapeutics Inc. (VKTX) NASDAQ

$82 (1.34) (-1.61%)

Market Cap: $8.24B

As of 03/28/24 04:00 PM EDT. Market closed.

(VKTX)

Viking Therapeutics Inc. (VKTX)
NASDAQ

$82
(1.34) (-1.61%)

Market Cap: $8.24B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

novel therapeutics for metabolic and endocrine ... read more

novel therapeutics for metabolic and endocrine disorders. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$485,000
CEO Compensation (Total)
$1.40M
URL
Address
12340 El Camino Real Ste 250, California, San Diego, 92130-3093.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Brian Lian
CEO Compensation (Base)
$485,000
CEO Compensation (Total)
$1.40M
Address
12340 El Camino Real Ste 250, California, San Diego, 92130-3093.
PRICE CHART FOR VIKING THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$83.56
Previous Close
$83.34
Days Range
$80.50 - $84.70
52 week range
$8.28 - $99.41
Volume
4,331,410
Avg. Volume (30 days)
9,135,884
Market Cap
$8.24B
Dividend Yield
-
P/E
-
Shares Outstanding
100,488,339
Open
$83.56
Previous Close
$83.34
Days Range
$80.50 - $84.70
52 week range
$8.28 - $99.41
Volume
4,331,410
Avg. Volume (30 days)
9,135,884
Market Cap
$8.24B
Dividend Yield
-
P/E
-
Shares Outstanding
100,488,339
FINANCIAL STATEMENTS FOR VIKING THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VIKING THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Mancini MariannaChief Operating OfficerMar 27, 2024 Option Exercise$83.3416,6101,384,277363,565Mar 27, 2024, 08:52 PM
Lian BrianPresident & CEOMar 27, 2024 Option Exercise$83.34153,94812,830,0262,266,453Mar 27, 2024, 08:51 PM
ZANTE GREGChief Financial OfficerMar 27, 2024 Option Exercise$83.3416,6101,384,277207,361Mar 27, 2024, 08:50 PM
Lian BrianPresident & CEOMar 01, 2024 Option Exercise$85.22162,81513,875,0942,198,734Mar 04, 2024, 07:54 PM
Mancini MariannaChief Operating OfficerMar 01, 2024 Option Exercise$85.2216,9581,445,161348,508Mar 04, 2024, 07:52 PM
ZANTE GREGChief Financial OfficerMar 01, 2024 Option Exercise$85.2220,0931,712,325192,304Mar 04, 2024, 07:50 PM
Lian BrianPresident & CEOFeb 09, 2024 Sale$29.9045,0001,345,5002,139,882Feb 09, 2024, 08:59 PM
Lian BrianPresident & CEOFeb 08, 2024 Option Exercise$3.76189,079711,3672,404,882Feb 08, 2024, 07:40 PM
Lian BrianPresident & CEOFeb 08, 2024 Sale$26.87269,0797,230,7842,344,882Feb 08, 2024, 07:40 PM
Rouan Sarah KathrynDirectorFeb 08, 2024 Option Exercise$8.3225,000208,00025,000Feb 08, 2024, 07:38 PM
Rouan Sarah KathrynDirectorFeb 08, 2024 Sale$28.0525,000701,2500Feb 08, 2024, 07:38 PM
Lian BrianPresident & CEOJan 31, 2024 Option Exercise$1.2385,000104,5502,349,882Jan 31, 2024, 08:39 PM
Lian BrianPresident & CEOJan 31, 2024 Sale$24.7185,0002,100,7502,309,882Jan 31, 2024, 08:39 PM
Lian BrianPresident & CEOJan 30, 2024 Option Exercise$1.2335,00043,0502,299,882Jan 30, 2024, 09:05 PM
Lian BrianPresident & CEOJan 30, 2024 Sale$23.9535,000838,2502,264,882Jan 30, 2024, 09:05 PM
Rouan Sarah KathrynDirectorJan 19, 2024 Option Exercise$8.3230,000249,60030,000Jan 19, 2024, 08:35 PM
Rouan Sarah KathrynDirectorJan 19, 2024 Sale$23.0530,000691,5000Jan 19, 2024, 08:35 PM
Lian BrianPresident & CEOJan 03, 2024 Option Exercise$17.40214,6403,734,7362,304,434Jan 04, 2024, 09:37 PM
Lian BrianPresident & CEOJan 04, 2024 Option Exercise$18.5839,552734,8762,264,882Jan 04, 2024, 09:37 PM
Mancini MariannaChief Operating OfficerJan 04, 2024 Option Exercise$18.5814,199263,817333,799Jan 04, 2024, 09:36 PM
Mancini MariannaChief Operating OfficerJan 03, 2024 Option Exercise$17.4049,210856,254347,998Jan 04, 2024, 09:36 PM
ZANTE GREGChief Financial OfficerJan 04, 2024 Option Exercise$18.5813,872257,742195,730Jan 04, 2024, 09:35 PM
ZANTE GREGChief Financial OfficerJan 03, 2024 Option Exercise$17.4049,122854,723209,602Jan 04, 2024, 09:35 PM
ZANTE GREGChief Financial OfficerJan 04, 2024 Sale$17.9015,000268,500180,730Jan 04, 2024, 09:35 PM
Rowland Charles A JrDirectorMay 16, 2023 Option Exercise$1.0840,00043,20070,000May 18, 2023, 06:31 PM
Rowland Charles A JrDirectorMay 16, 2023 Sale$25.0040,0001,000,00030,000May 18, 2023, 06:31 PM
MACARTNEY LAWSONDirectorMay 16, 2023 Option Exercise$1.1916,00019,04063,965May 18, 2023, 06:30 PM
MACARTNEY LAWSONDirectorMay 16, 2023 Sale$24.0016,000384,00047,965May 18, 2023, 06:30 PM
Lian BrianPresident & CEOMay 01, 2023 Sale$22.4545,0001,010,2502,197,963May 01, 2023, 07:03 PM
MACARTNEY LAWSONDirectorApr 24, 2023 Option Exercise$3.3316,00053,28063,965Apr 24, 2023, 07:31 PM
MACARTNEY LAWSONDirectorApr 24, 2023 Sale$22.0016,000352,06147,965Apr 24, 2023, 07:31 PM
Lian BrianPresident & CEOApr 19, 2023 Sale$21.4535,000750,7502,242,963Apr 21, 2023, 07:29 PM
MACARTNEY LAWSONDirectorApr 17, 2023 Option Exercise$8.0020,786166,28868,751Apr 18, 2023, 07:10 PM
MACARTNEY LAWSONDirectorApr 17, 2023 Sale$20.0020,786415,72047,965Apr 18, 2023, 07:10 PM
Lian BrianPresident & CEOApr 17, 2023 Option Exercise$2.15125,000268,7502,432,963Apr 18, 2023, 07:09 PM
Lian BrianPresident & CEOApr 17, 2023 Sale$20.45155,0003,169,7652,277,963Apr 18, 2023, 07:09 PM
Mancini MariannaChief Operating OfficerApr 17, 2023 Option Exercise$13.0712,500163,375300,263Apr 18, 2023, 07:08 PM
Mancini MariannaChief Operating OfficerApr 17, 2023 Sale$20.0012,500250,000287,763Apr 18, 2023, 07:08 PM
ZANTE GREGChief Financial OfficerApr 17, 2023 Option Exercise$13.077,50098,025156,779Apr 18, 2023, 07:07 PM
ZANTE GREGChief Financial OfficerApr 17, 2023 Sale$20.007,500150,000149,279Apr 18, 2023, 07:07 PM
Lian BrianPresident & CEOApr 13, 2023 Option Exercise$1.8854,336102,1522,387,299Apr 13, 2023, 05:14 PM
Lian BrianPresident & CEOApr 13, 2023 Sale$18.4579,3361,463,7492,307,963Apr 13, 2023, 05:14 PM
ZANTE GREGChief Financial OfficerApr 12, 2023 Option Exercise$5.9941,544249,026190,823Apr 13, 2023, 05:13 PM
ZANTE GREGChief Financial OfficerApr 11, 2023 Option Exercise$5.2556,295295,778205,574Apr 13, 2023, 05:13 PM
ZANTE GREGChief Financial OfficerApr 12, 2023 Sale$18.0041,544747,792149,279Apr 13, 2023, 05:13 PM
ZANTE GREGChief Financial OfficerApr 11, 2023 Sale$18.0056,2951,013,518149,279Apr 13, 2023, 05:13 PM
Lian BrianPresident & CEOApr 03, 2023 Option Exercise$17.57200,0003,514,0002,332,963Apr 03, 2023, 07:26 PM
Lian BrianPresident & CEOMar 31, 2023 Option Exercise$9.4967,970645,0352,322,933Apr 03, 2023, 07:26 PM
Lian BrianPresident & CEOMar 30, 2023 Option Exercise$2.42135,382327,8382,408,345Apr 03, 2023, 07:26 PM
Lian BrianPresident & CEOApr 03, 2023 Sale$17.8522,000392,7002,232,963Apr 03, 2023, 07:26 PM
Lian BrianPresident & CEOMar 31, 2023 Sale$17.4567,9701,186,0772,254,963Apr 03, 2023, 07:26 PM
Lian BrianPresident & CEOMar 30, 2023 Sale$17.16153,3822,632,5162,320,345Apr 03, 2023, 07:26 PM
ZANTE GREGChief Financial OfficerApr 03, 2023 Option Exercise$17.5755,166969,267149,279Apr 03, 2023, 07:24 PM
ZANTE GREGChief Financial OfficerApr 03, 2023 Option Exercise$7.7730,911240,178178,689Apr 03, 2023, 07:24 PM
ZANTE GREGChief Financial OfficerMar 30, 2023 Option Exercise$7.2993,750683,483278,807Apr 03, 2023, 07:24 PM
ZANTE GREGChief Financial OfficerApr 03, 2023 Sale$18.0030,911556,398147,778Apr 03, 2023, 07:24 PM
ZANTE GREGChief Financial OfficerMar 30, 2023 Sale$17.00131,0292,227,821147,778Apr 03, 2023, 07:24 PM
Mancini MariannaChief Operating OfficerMar 30, 2023 Option Exercise$17.5730,799541,138287,763Apr 03, 2023, 07:22 PM
Mancini MariannaChief Operating OfficerMar 30, 2023 Option Exercise$12.5672,200907,151297,995Apr 03, 2023, 07:22 PM
Mancini MariannaChief Operating OfficerMar 29, 2023 Option Exercise$9.1315,000136,950303,137Mar 30, 2023, 09:04 PM
Mancini MariannaChief Operating OfficerMar 28, 2023 Option Exercise$2.37167,427397,193484,700Mar 30, 2023, 09:04 PM
Mancini MariannaChief Operating OfficerMar 29, 2023 Sale$16.0041,242659,872261,895Mar 30, 2023, 09:04 PM
Mancini MariannaChief Operating OfficerMar 28, 2023 Sale$15.00196,5632,948,445288,137Mar 30, 2023, 09:04 PM
Mancini MariannaChief Operating OfficerJan 15, 2023 Option Exercise$8.951,0799,657317,273Jan 17, 2023, 07:39 PM
ZANTE GREGChief Financial OfficerJan 03, 2023 Option Exercise$8.5223,933203,909205,765Jan 04, 2023, 06:25 PM
ZANTE GREGChief Financial OfficerDec 30, 2022 Option Exercise$9.4019,697185,152139,031Jan 04, 2023, 06:25 PM
ZANTE GREGChief Financial OfficerJan 04, 2023 Option Exercise$8.4220,708174,361185,057Jan 04, 2023, 06:25 PM
Mancini MariannaChief Operating OfficerJan 04, 2023 Option Exercise$8.4213,994117,829318,352Jan 04, 2023, 06:24 PM
Mancini MariannaChief Operating OfficerJan 03, 2023 Option Exercise$8.5218,854160,636332,346Jan 04, 2023, 06:24 PM
Mancini MariannaChief Operating OfficerDec 30, 2022 Option Exercise$9.4012,773120,066260,533Jan 04, 2023, 06:24 PM
Lian BrianPresident & CEODec 30, 2022 Option Exercise$9.4066,127621,5942,103,167Jan 04, 2023, 06:24 PM
Lian BrianPresident & CEOJan 04, 2023 Option Exercise$8.4228,619240,9722,272,963Jan 04, 2023, 06:24 PM
Lian BrianPresident & CEOJan 03, 2023 Option Exercise$8.5268,252581,5072,301,582Jan 04, 2023, 06:24 PM
FOEHR MATTHEW WDirectorMay 02, 2022 Buy$2.4745,000111,195111,250May 03, 2022, 04:12 PM
Mancini MariannaChief Operating OfficerJan 15, 2022 Option Exercise$4.248273,506238,695Feb 11, 2022, 06:34 PM
ZANTE GREGChief Financial OfficerJan 04, 2022 Option Exercise$4.628,83540,818136,304Jan 05, 2022, 07:13 PM
ZANTE GREGChief Financial OfficerJan 03, 2022 Option Exercise$4.883,09715,11391,806Jan 05, 2022, 07:13 PM
Mancini MariannaChief Operating OfficerJan 03, 2022 Option Exercise$4.883,91919,125174,034Jan 05, 2022, 07:12 PM
Mancini MariannaChief Operating OfficerJan 04, 2022 Option Exercise$4.6211,84554,724239,522Jan 05, 2022, 07:12 PM
Lian BrianPresident & CEOJan 04, 2022 Option Exercise$4.6226,432122,1162,036,686Jan 05, 2022, 07:12 PM
Lian BrianPresident & CEOJan 03, 2022 Option Exercise$4.8836,319177,2371,889,785Jan 05, 2022, 07:12 PM
Lian BrianPresident & CEOSep 28, 2021 Option Exercise$6.5027,750180,3751,924,807Sep 30, 2021, 05:48 PM
Mancini MariannaChief Operating OfficerSep 28, 2021 Option Exercise$6.502,83918,454177,535Sep 30, 2021, 05:45 PM
ZANTE GREGChief Financial OfficerSep 28, 2021 Option Exercise$6.502,30614,98994,485Sep 30, 2021, 05:43 PM
FOEHR MATTHEW WDirectorJun 10, 2021 Buy$5.6920,000113,80066,250Jun 10, 2021, 04:57 PM
FOEHR MATTHEW WDirectorMar 22, 2021 Option Exercise$1.5020,00030,00046,250Mar 25, 2021, 09:30 PM
ZANTE GREGChief Financial OfficerJan 19, 2021 Option Exercise$6.688085,39789,751Jan 19, 2021, 06:25 PM
Mancini MariannaChief Operating OfficerJan 19, 2021 Option Exercise$6.689946,640169,952Jan 19, 2021, 06:23 PM
Mancini MariannaChief Operating OfficerJan 15, 2021 Option Exercise$6.486864,445170,946Jan 19, 2021, 06:23 PM
MORNEAU MICHAELVP, Finance and AdministrationJan 19, 2021 Option Exercise$6.681,68511,256116,062Jan 19, 2021, 06:21 PM
Lian BrianPresident & CEOJan 19, 2021 Option Exercise$6.685,61137,4811,894,181Jan 19, 2021, 06:19 PM
Lian BrianPresident & CEOJan 04, 2021 Option Exercise$5.8016,97398,4431,899,792Jan 06, 2021, 04:34 PM
Lian BrianPresident & CEOJan 03, 2021 Option Exercise$5.6331,545177,5981,712,432Jan 06, 2021, 04:34 PM
ZANTE GREGChief Financial OfficerJan 04, 2021 Option Exercise$5.802,78716,16590,559Jan 06, 2021, 04:28 PM
Mancini MariannaChief Operating OfficerJan 04, 2021 Option Exercise$5.802,77316,083171,632Jan 06, 2021, 04:26 PM
MORNEAU MICHAELVP, Finance and AdministrationJan 04, 2021 Option Exercise$5.802,73915,886117,747Jan 06, 2021, 12:00 AM
MORNEAU MICHAELVP, Finance and AdministrationSep 15, 2020 Option Exercise$6.251,5579,73197,873Sep 16, 2020, 05:21 PM
Lian BrianPresident & CEOSep 15, 2020 Option Exercise$6.2519,192119,9501,742,363Sep 16, 2020, 05:18 PM
LIGAND PHARMACEUTICALS INC10% OwnerAug 26, 2020 Sale$8.11148,7001,205,6605,819,383Aug 28, 2020, 05:11 PM
LIGAND PHARMACEUTICALS INC10% OwnerAug 26, 2020 Sale$8.1194,488766,1095,819,383Aug 27, 2020, 07:06 PM
LIGAND PHARMACEUTICALS INC10% OwnerAug 25, 2020 Sale$8.0270,000561,5755,968,083Aug 27, 2020, 07:06 PM
FOEHR MATTHEW WDirectorJun 30, 2020 Sale$7.3513,00095,55026,250Jun 30, 2020, 05:54 PM
Lian BrianPresident & CEOJan 19, 2020 Option Exercise$7.183,19522,9401,704,312Jan 21, 2020, 05:39 PM
MORNEAU MICHAELVP, Finance and AdministrationJan 19, 2020 Option Exercise$7.182,04414,67692,840Jan 21, 2020, 05:35 PM
Lian BrianPresident & CEOJan 03, 2020 Option Exercise$7.776,78252,6961,707,507Jan 03, 2020, 08:01 PM
MORNEAU MICHAELVP, Finance and AdministrationJan 19, 2019 Option Exercise$8.782,04417,94691,991Jan 22, 2019, 07:13 PM
Lian BrianPresident & CEOJan 19, 2019 Option Exercise$8.784,33338,0441,560,152Jan 22, 2019, 07:13 PM
LIGAND PHARMACEUTICALS INC10% OwnerSep 25, 2018 Sale$19.15262,8815,034,2506,038,083Sep 27, 2018, 09:25 PM
SINGLETON J MATTHEWDirectorMay 31, 2018 Buy$9.829,50093,2619,500May 31, 2018, 07:04 PM
MORNEAU MICHAELVP, Finance and AdministrationMay 31, 2018 Sale$9.2521,551199,34794,035May 31, 2018, 07:03 PM
Rowland Charles A JrDirectorMay 29, 2018 Buy$5.1630,000154,80030,000May 31, 2018, 07:02 PM
Webster Stephen WDirectorMay 29, 2018 Buy$5.218,00041,7128,000May 31, 2018, 06:59 PM
MACARTNEY LAWSONDirectorMay 29, 2018 Buy$5.2247,965250,32947,965May 31, 2018, 06:57 PM
MORNEAU MICHAELVP, Finance and AdministrationMay 04, 2018 Option Exercise$4.227,61632,14094,035May 08, 2018, 08:37 PM
Lian BrianPresident & CEOMay 04, 2018 Option Exercise$4.2210,08642,5631,483,012May 08, 2018, 08:37 PM
MORNEAU MICHAELChief Financial OfficerMay 04, 2017 Option Exercise$1.348,19210,97780,604May 05, 2017, 06:25 PM
FOEHR MATTHEW WDirectorNov 15, 2016 Buy$1.2113,00015,67839,250Nov 15, 2016, 04:34 PM
Hanley RochelleChief Medical OfficerMay 04, 2016 Option Exercise$1.3110,59513,879160,836May 05, 2016, 05:36 PM
LIGAND PHARMACEUTICALS INC10% OwnerApr 13, 2016 Option Exercise$1.25960,0001,200,0006,300,964Apr 15, 2016, 05:19 PM
FOEHR MATTHEW WDirectorApr 13, 2016 Buy$1.2420,00024,80026,250Apr 13, 2016, 06:17 PM
Lian BrianPresident & CEOMay 04, 2015 Option Exercise$9.4916,346155,1241,453,098May 06, 2015, 08:20 PM
Dinerman MichaelChief Operating OfficerMay 04, 2015 Option Exercise$9.498,72482,791694,116May 06, 2015, 08:19 PM
MORNEAU MICHAELChief Financial OfficerMay 04, 2015 Option Exercise$9.4910,40498,73477,404May 06, 2015, 07:20 PM
Hanley RochelleChief Medical OfficerMay 04, 2015 Option Exercise$9.497,30869,353168,855May 06, 2015, 07:18 PM
FOEHR MATTHEW WDirectorMay 04, 2015 Buy$8.006,25050,0006,250May 05, 2015, 01:47 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Mancini MariannaChief Operating Officer03/27/20241,384,277
Lian BrianPresident & CEO03/27/202412,830,026
ZANTE GREGChief Financial Officer03/27/20241,384,277
Lian BrianPresident & CEO03/01/202413,875,094
Mancini MariannaChief Operating Officer03/01/20241,445,161
ZANTE GREGChief Financial Officer03/01/20241,712,325
Lian BrianPresident & CEO02/09/20241,345,500
Lian BrianPresident & CEO02/08/2024711,367
Lian BrianPresident & CEO02/08/20247,230,784
Rouan Sarah KathrynDirector02/08/2024208,000
Rouan Sarah KathrynDirector02/08/2024701,250
Lian BrianPresident & CEO01/31/2024104,550
Lian BrianPresident & CEO01/31/20242,100,750
Lian BrianPresident & CEO01/30/202443,050
Lian BrianPresident & CEO01/30/2024838,250
Rouan Sarah KathrynDirector01/19/2024249,600
Rouan Sarah KathrynDirector01/19/2024691,500
Lian BrianPresident & CEO01/03/20243,734,736
Lian BrianPresident & CEO01/04/2024734,876
Mancini MariannaChief Operating Officer01/04/2024263,817
Mancini MariannaChief Operating Officer01/03/2024856,254
ZANTE GREGChief Financial Officer01/04/2024257,742
ZANTE GREGChief Financial Officer01/03/2024854,723
ZANTE GREGChief Financial Officer01/04/2024268,500
Rowland Charles A JrDirector05/16/202343,200
Rowland Charles A JrDirector05/16/20231,000,000
MACARTNEY LAWSONDirector05/16/202319,040
MACARTNEY LAWSONDirector05/16/2023384,000
Lian BrianPresident & CEO05/01/20231,010,250
MACARTNEY LAWSONDirector04/24/202353,280
MACARTNEY LAWSONDirector04/24/2023352,061
Lian BrianPresident & CEO04/19/2023750,750
MACARTNEY LAWSONDirector04/17/2023166,288
MACARTNEY LAWSONDirector04/17/2023415,720
Lian BrianPresident & CEO04/17/2023268,750
Lian BrianPresident & CEO04/17/20233,169,765
Mancini MariannaChief Operating Officer04/17/2023163,375
Mancini MariannaChief Operating Officer04/17/2023250,000
ZANTE GREGChief Financial Officer04/17/202398,025
ZANTE GREGChief Financial Officer04/17/2023150,000
Lian BrianPresident & CEO04/13/2023102,152
Lian BrianPresident & CEO04/13/20231,463,749
ZANTE GREGChief Financial Officer04/12/2023249,026
ZANTE GREGChief Financial Officer04/11/2023295,778
ZANTE GREGChief Financial Officer04/12/2023747,792
ZANTE GREGChief Financial Officer04/11/20231,013,518
Lian BrianPresident & CEO04/03/20233,514,000
Lian BrianPresident & CEO03/31/2023645,035
Lian BrianPresident & CEO03/30/2023327,838
Lian BrianPresident & CEO04/03/2023392,700
Lian BrianPresident & CEO03/31/20231,186,077
Lian BrianPresident & CEO03/30/20232,632,516
ZANTE GREGChief Financial Officer04/03/2023969,267
ZANTE GREGChief Financial Officer04/03/2023240,178
ZANTE GREGChief Financial Officer03/30/2023683,483
ZANTE GREGChief Financial Officer04/03/2023556,398
ZANTE GREGChief Financial Officer03/30/20232,227,821
Mancini MariannaChief Operating Officer03/30/2023541,138
Mancini MariannaChief Operating Officer03/30/2023907,151
Mancini MariannaChief Operating Officer03/29/2023136,950
Mancini MariannaChief Operating Officer03/28/2023397,193
Mancini MariannaChief Operating Officer03/29/2023659,872
Mancini MariannaChief Operating Officer03/28/20232,948,445
Mancini MariannaChief Operating Officer01/15/20239,657
ZANTE GREGChief Financial Officer01/03/2023203,909
ZANTE GREGChief Financial Officer12/30/2022185,152
ZANTE GREGChief Financial Officer01/04/2023174,361
Mancini MariannaChief Operating Officer01/04/2023117,829
Mancini MariannaChief Operating Officer01/03/2023160,636
Mancini MariannaChief Operating Officer12/30/2022120,066
Lian BrianPresident & CEO12/30/2022621,594
Lian BrianPresident & CEO01/04/2023240,972
Lian BrianPresident & CEO01/03/2023581,507
FOEHR MATTHEW WDirector05/02/2022111,195
Mancini MariannaChief Operating Officer01/15/20223,506
ZANTE GREGChief Financial Officer01/04/202240,818
ZANTE GREGChief Financial Officer01/03/202215,113
Mancini MariannaChief Operating Officer01/03/202219,125
Mancini MariannaChief Operating Officer01/04/202254,724
Lian BrianPresident & CEO01/04/2022122,116
Lian BrianPresident & CEO01/03/2022177,237
Lian BrianPresident & CEO09/28/2021180,375
Mancini MariannaChief Operating Officer09/28/202118,454
ZANTE GREGChief Financial Officer09/28/202114,989
FOEHR MATTHEW WDirector06/10/2021113,800
FOEHR MATTHEW WDirector03/22/202130,000
ZANTE GREGChief Financial Officer01/19/20215,397
Mancini MariannaChief Operating Officer01/19/20216,640
Mancini MariannaChief Operating Officer01/15/20214,445
MORNEAU MICHAELVP, Finance and Administration01/19/202111,256
Lian BrianPresident & CEO01/19/202137,481
Lian BrianPresident & CEO01/04/202198,443
Lian BrianPresident & CEO01/03/2021177,598
ZANTE GREGChief Financial Officer01/04/202116,165
Mancini MariannaChief Operating Officer01/04/202116,083
MORNEAU MICHAELVP, Finance and Administration01/04/202115,886
MORNEAU MICHAELVP, Finance and Administration09/15/20209,731
Lian BrianPresident & CEO09/15/2020119,950
LIGAND PHARMACEUTICALS INC10% Owner08/26/20201,205,660
LIGAND PHARMACEUTICALS INC10% Owner08/26/2020766,109
LIGAND PHARMACEUTICALS INC10% Owner08/25/2020561,575
FOEHR MATTHEW WDirector06/30/202095,550
Lian BrianPresident & CEO01/19/202022,940
MORNEAU MICHAELVP, Finance and Administration01/19/202014,676
Lian BrianPresident & CEO01/03/202052,696
MORNEAU MICHAELVP, Finance and Administration01/19/201917,946
Lian BrianPresident & CEO01/19/201938,044
LIGAND PHARMACEUTICALS INC10% Owner09/25/20185,034,250
SINGLETON J MATTHEWDirector05/31/201893,261
MORNEAU MICHAELVP, Finance and Administration05/31/2018199,347
Rowland Charles A JrDirector05/29/2018154,800
Webster Stephen WDirector05/29/201841,712
MACARTNEY LAWSONDirector05/29/2018250,329
MORNEAU MICHAELVP, Finance and Administration05/04/201832,140
Lian BrianPresident & CEO05/04/201842,563
MORNEAU MICHAELChief Financial Officer05/04/201710,977
FOEHR MATTHEW WDirector11/15/201615,678
Hanley RochelleChief Medical Officer05/04/201613,879
LIGAND PHARMACEUTICALS INC10% Owner04/13/20161,200,000
FOEHR MATTHEW WDirector04/13/201624,800
Lian BrianPresident & CEO05/04/2015155,124
Dinerman MichaelChief Operating Officer05/04/201582,791
MORNEAU MICHAELChief Financial Officer05/04/201598,734
Hanley RochelleChief Medical Officer05/04/201569,353
FOEHR MATTHEW WDirector05/04/201550,000
Load More Insider Transactions
FUNDS WITH A POSITION IN VIKING THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.7,605,8670.00361%6.66%Other
VIKING GLOBAL INVESTORS LP5,145,1120.35%12.5%Growth At A Reasonable Price
BALYASNY ASSET MANAGEMENT L.P.2,243,5230.08%5.73%Event Driven
GEODE CAPITAL MANAGEMENT, LLC2,128,3430.00414%5.01%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)1,279,0000.44%No changeOther
BALYASNY ASSET MANAGEMENT L.P.125,000 (Call)0.00437%-87.98%Event Driven
BAMCO INC /NY/310,0670.02%NewGrowth At A Reasonable Price
D. E. SHAW & CO., INC.115,6350.00188%34.49%Other
ALPS ADVISORS INC66,3770.00971%-10.06%Other
UBS OCONNOR LLC22,1410.03%-61.76%Value
AQR CAPITAL MANAGEMENT LLC47,4590.00166%-14.74%Other
ROYCE & ASSOCIATES LP28,0370.00482%NewValue
CHANGE IN SHARES OUTSTANDING FOR VIKING THERAPEUTICS INC
STOCK BUYBACKS FOR VIKING THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.10%
1Q
12/31/2023
06/30/2023
0.94%
2Q
12/31/2023
03/31/2023
27.56%
3Q
12/31/2023
12/31/2022
30.50%
4Q
12/31/2023
09/30/2022
30.64%
5Q
12/31/2023
06/30/2022
30.07%
6Q
12/31/2023
03/31/2022
29.11%
7Q
12/31/2023
12/31/2021
28.02%
8Q
12/31/2023
09/30/2021
28.12%
9Q
12/31/2023
06/30/2021
28.30%
10Q
12/31/2023
03/31/2021
33.65%
11Q
12/31/2023
12/31/2020
37.10%
12Q
12/31/2023
09/30/2020
37.58%
13Q
12/31/2023
06/30/2020
37.88%
14Q
12/31/2023
03/31/2020
38.13%
15Q
12/31/2023
12/31/2019
38.59%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.10%
1Q
06/30/2023
0.94%
2Q
03/31/2023
27.56%
3Q
12/31/2022
30.50%
4Q
09/30/2022
30.64%
5Q
06/30/2022
30.07%
6Q
03/31/2022
29.11%
7Q
12/31/2021
28.02%
8Q
09/30/2021
28.12%
9Q
06/30/2021
28.30%
10Q
03/31/2021
33.65%
11Q
12/31/2020
37.10%
12Q
09/30/2020
37.58%
13Q
06/30/2020
37.88%
14Q
03/31/2020
38.13%
15Q
12/31/2019
38.59%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VIKING THERAPEUTICS INC
LOADING...